Azilsartan National NME Drug Monograph

Valsartan and candesartan are approved for the treatment of patients with heart failure, and valsartan is also indicated for reducing cardiovascular mortality in patients with left ventricular failure or left ventricular dysfunction post myocardial infarction.2 ... the following drug classes may be considered in patients who are inadequately ... ................
................